<table border="1"><tr><th>Name (IUPAC) systematic</th><td><ul><li>Acid 2-[1-(aminomethyl)cyclohexil]ethanoic</li></ul></td></tr><tr><th>CAS number</th><td><ul><li>60142-96-3</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li> N03 | AX12</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>3446</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>APRD00015</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C = 9</li></ul></td></tr><tr><th>Weight mol.</th><td><ul><li>171.237 g/mol</li></ul></td></tr><tr><th>Bioavailability</th><td><ul><li> rapid, in part by a transport system of L-amino acids mediated by saturable transporter | 60% by 0.9 g daily to 27% by 4.8 g daily dose | Food increases absorption by 14%</li></ul></td></tr><tr><th>Protein Union</th><td><ul><li> less than 3%</li></ul></td></tr><tr><th>Metabolism</th><td><ul><li>is not metabolised practically</li></ul></td></tr><tr><th>Average life</th><td><ul><li>5 to 7 h</li></ul></td></tr><tr><th>Excretion</th><td><ul><li> renal</li></ul></td></tr><tr><th>Commercial name</th><td><ul><li> Fanatrex, Gabarone, Gralise, Neurontin, Nupentin, Neogab</li></ul></td></tr><tr><th>Cat. pregnancy</th><td><ul><li> D | (AU) | Evidence of risk to the foetus, although the potential benefit of its use in pregnant women may be acceptable despite the likely risk only in some situations. It is at the discretion of the treating physician. | (USA)</li></ul></td></tr><tr><th>Legal status</th><td><ul><li>Rx only</li></ul></td></tr><tr><th>Adm. routes</th><td><ul><li>Oral</li></ul></td></tr></table>